OncoHost at ISLB 2026
Nov 7–9, 2026 Madrid, Spain ~700 attendees Website
OncoHost brings 1 presentation to ISLB 2026 in Madrid, and exhibits at Booth 8. Its work centres on blood protein profiling as a way to predict how patients respond to immunotherapy. One study follows these protein profiles over time in non-small cell lung cancer to predict response and overall survival.
| Organization | ISLB 2026 Attendance |
|---|---|
OncoHost Binyamina, Israel | ◇Bronze Sponsor |
Offers PROphet, a blood proteomics platform; its PROphetNSCLC test informs first-line immunotherapy decisions in non-small cell lung cancer. | Booth Exhibiting at Booth 8 Sat, Nov 710:00am–4:00pm, 6:00–7:30pmSun, Nov 810:00am–4:00pmMon, Nov 98:30am–10:30am Industry Sat Nov 7 11:50am–12:10pm Session Sat Nov 7 1:45pm–3:15pm |
Instantly find 20 buyers from OncoHost
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction